The c-myc proto-oncogene is deregulated in a variety of human malignancies and is implicated in the control of cellular proliferation, dierentiation and apoptosis (Henriksson and Luscher, 1996) . c-Myc expression is induced upon mitogenic signaling and peaks 3 ± 4 h after growth factor stimulation (Kelly et al., 1983) . In cycling cells, c-Myc levels remain invariant and decline after induction of dierentiation (Einat et al., 1985; Pietenpol et al., 1990) . Activation of c-myc is sucient to induce cell cycle entry in quiescent cells (Eilers et al., 1991) . Conversely, inhibition of c-myc expression using antisense methods leads to growth arrest and induction of dierentiation (Biro et al., 1993; Heikkila et al., 1987; Prochownik et al., 1988) .
The c-Myc protein is a transcription factor of the helix ± loop ± helix ± zipper class, which must dimerize with its partner Max, in order to bind DNA and transactivate from speci®c Myc sites (Blackwood and Eisenman, 1991; Kretzner et al., 1992) . The prevailing model has been that the transactivation of c-Myc target genes is required for its growth-promoting properties. Many genes have been implicated as cMyc targets, including genes involved in cell cycle regulation: cdc25A, cyclin E, cyclin D2 (Bouchard et al., 1999; Galaktionov et al., 1996; Perez-Roger et al., 1997) ; apoptosis: p53 (Reisman et al., 1993) ; DNA biosynthesis: cad, ODC (Bello et al., 1993; Miltenberger et al., 1995) ; macromolecular synthesis: eIF-4E and MrDb (Grandori et al., 1996; Rosenwald, 1996) ; and genes with unknown function: rcl and a-prothymosin (Eilers et al., 1991; Lewis et al., 1997) . Myc proteins have also been implicated in the repression of several genes including MHC class I antigens, c-myc, gadd45 and C/EBP (Bernards et al., 1986; Li et al., 1994; Marhin et al., 1997; Penn et al., 1990) . For many genes it is still unclear whether they are direct or indirect targets and none of them appears to explain the diverse biological activities of c-Myc.
The generation of c-myc de®cient Rat1 ®broblasts provides a new experimental system to search for genes that can substitute for c-Myc in proliferation. These cmyc 7/7 cells are viable but proliferate approximately three times slower than their wild type counterparts, a phenotype that can be rescued by ectopic expression of c-myc (Mateyak et al., 1997) . It was shown that cmyc 7/7 cells have a reduced activity of all cyclin/CDK complexes, and CDK7 and p27 were implicated as downstream eectors of c-Myc (Mateyak et al., 1999) . Interestingly, when these cells were analysed for expression of several putative c-Myc-regulated genes, only the expression of cad and gadd45 appeared to be aected, suggesting that many of the proposed c-Mycactivated genes do not contribute to the growth defect of the c-myc null cells (Bush et al., 1998) . Although the mechanism of c-Myc-induced repression is still unclear, accumulating evidence suggests that gene repression may be sucient for many aspects of c-Myc function. For example, a mutated c-Myc lacking Myc Box II (amino acid 106 ± 143), which can still transactivate from Myc sites in reporter assays but has lost its repression function, is inactive in transformation assays (Kato et al., 1990; Li et al., 1994; Marhin et al., 1997; Stone et al., 1987) . Furthermore, recent studies with the transactivation defective c-MycS protein showed that it retains the ability to stimulate proliferation and (Morgenstern and Land, 1990) were packaged in the Phoenix producer cell line. The c-myc null Rat1A cells (Mateyak et al., 1997) and wild type Rat1A cells were infected with the indicated retroviruses and polyclonal cell lines were generated by hygromycin selection (100 mg/ml; Calbiochem) for 2 weeks. The selected cells were seeded in six well plates (5.10 4 cells per well) and the relative cell numbers were calculated at the indicated time points by staining the cells with crystal violet (Sigma) and determining the optical density at 590 nm . The growth rates were determined in multiple independent experiments from which one representative experiment is shown. (b) Immunoblot analysis of the retrovirally infected polyclonal cell lines, (7): control pBabe-hygro infected Rat1A cells; (+): Rat 1A cells infected with the indicated cDNA in the pBabe-hygro vector, was performed as described (Berns et al., 1997) . The following antibodies were used: c-Myc: PAN-Myc (Genosys Biotechnologies, OA-11-802); cyclin D1: H-285 (Santa Cruz, SC-753); cyclin D2: C-17 (SC-181); cyclin E: C-19 (SC-198); E2F-1: C-20 (SC-193); E2F-2: C-20 (SC-633); E2F-3: C-18 (SC-878); Ras: (Transduction laboratories, R 02120); SV40 T antigen: monoclonal 419 (kindly provided by Dr AJ van der Eb); SKP2: anity puri®ed rabbit antip45 (a kind gift from Dr W Krek). (c) Duration of the cell cycle phases. The times spent in the G0/G1, S and G2/M phases were calculated from cell cycle distribution as determined by¯ow cytometry of asynchronously growing populations (data not shown) and the doubling times as determined in a. One representative experiment is shown. (d) Target gene activation by E2F1. Western analysis of the E2F1 overexpressing c-myc null cell line shows that E2F1 is functional in the induction of one of its targets, cyclin E apoptosis and can substitute for full-length c-Myc in cmyc null cells (Xiao et al., 1998) . To understand the molecular mechanism by which c-Myc exerts its growth control, the identi®cation of functional equivalents of c-Myc may be very helpful. In this study we describe functional genetic screens in c-myc 7/7 cells to search for genes that can revert their slow growth phenotype.
First, we investigated whether a defect in a known cell cycle pathway could account for the slow growth phenotype of the c-myc null cells. To test this, we infected the c-myc null cells with retroviral vectors expressing either c-Myc (as a positive control), SV40 Tantigen, adenovirus E1A (13S), RasV12, SKP2, E2F1 (which activates the c-Myc target gene CDC25A (Vigo et al., 1999) ), E2F2, E2F3, cyclin D1, cyclin D2 or cyclin E. Cell lines were generated by hygromycin selection for 2 weeks and analysed for reversion of the slow growth phenotype. All cell lines were tested by Western analysis for the expression of the introduced cell cycle proteins (Figure 1b) . Only in the case of stable c-Myc expression, the growth rate of the c-myc null cells was restored to wild type levels ( Figure 1a) . Interestingly, ectopic expression of SV40 T-antigen, which aects both the pRb and p53 pathways had no eect on the growth properties of the c-myc nulls. Moreover, it is striking that expression of adenovirus 5 E1A had no eect on the growth rate since c-Myc and E1A behave similar in many growth assays. Perhaps even more importantly, c-Myc-E1A chimeric proteins have immortalizing activity, suggesting that growth regulation by c-myc and E1A involves interactions with common substrates (Ralston, 1991) . The cDNAs used to establish the polyclonal cell lines depicted in Figure  1a have all been tested in functional assays in our lab and by others. Although none of the cell cycle genes tested rescued the c-myc null defect in long term growth, it remained possible that some of the defects in the c-myc null cells, such as the G1 or S phase delay, could be rescued. Therefore, we used¯ow cytometry on exponentially growing E2F-overexpressing c-myc null cell lines (data not shown). Together with the cell doubling times as determined from the growth curves shown in Figure 1a , the number of hours spent in each of the cell cycle phases was determined. Figure 1c shows that ectopic expression of E2F1, 2 or 3 had no eect on the duration of the cell cycle phases, whereas c-myc restored the hours spent in each phase to wild type levels. Nevertheless, ectopic expression of E2F1 caused an increase in cyclin E expression (Figure 1d ), indicating that E2F1 is functionally active in these cells.
The growth curves presented here extend earlier work of others (Mateyak et al., 1999) , which showed that ectopic expression of cyclin D1, cyclin E and cyclin A did not revert the c-myc null phenotype. Our data indicate that many of the genes that act in G1 to S phase transition are not responsible for the growth defect of the c-myc null cells.
To perform an unbiased search for genes that rescue the growth defect of c-myc null cells we performed a functional screen with retroviral cDNA expression libraries. As was previously reported, the slow growth phenotype of the c-myc null cells is very stable and in all the screens described here, no spontaneous rescue of the slow growth phenotype was observed in the control infections with GFP virus (Table 1) . In these screens, 1 ± 2.10 6 cDNA library-infected cells (which carried on average 1 ± 3 proviruses per cell) were subdivided in pools and subsequently cultured as depicted in Figure  2a . Fast-growing colonies became visible 4 to 5 weeks after infection (Figure 2b ). In almost all cases, the rescued cells had undergone a morphological change in that they were smaller and grew to higher density, which resembles the changes evoked by reintroduction of c-myc.
The ®rst rescue screen was performed with a retroviral expression library made from size-fractionated K562 human erythroleukemia cDNA. Rescued colonies were only identi®ed in the small size fraction (1 ± 3 kb cDNA size) of the K562 library (Table 1) . Multiple rescued colonies from each pool were isolated. Since c-myc is a likely candidate to be cloned in this Construction of the K562 and JEG3 retroviral cDNA libraries in the pMXsubF retroviral vector will be described elsewhere. The whole mouse embryo retroviral cDNA expression library was purchased from Clontech (ML8000BB). High titer library retroviral stocks were generated by transfecting 15 cm plates of Phoenix cells with 50 mg of cDNA library plasmid, 2.5 mg of pEGFP-N1 (Clontech) and 5 ng of pMXsubF-GFP. Virus supernatants were only collected when transfection eciencies were higher than 60% (as determined by scoring GFP-positive cells using ā uorescence microscope). Rough estimates of the library virus titers were obtained through the use of the 1:10 000 diluted GFP virus present in the library stocks. For the PCR analysis of the JEG3 and K562 rescuing cDNAs, the primers gag:AAAGGACCTTACACAGTCCTGCTGA and subF:CCACAGGTAATGCTTTTACTGGCCT were used. For the mouse embryo retroviral cDNA library from Clontech we generated the primers pLibFW1:CCCCCTTGAACCTCCTCGTTCGAC and pLibREV2:TGGCGTTACTTAAGCTAGCTTGCCAAA. Genomic DNA was isolated with the use of DNAzol (Gibco ± BRL), and 100 ng DNA was used per PCR reaction. For the PCR, Expand Long Template (Boehringer Mannheim) was combined with Taqstart+dilution buer (Clontech) in a 1 : 1 : 4 ratio. The PCR reaction conditions were: 948C (2 min); 948C (20 s); 658C (30 s); 688C (5 min); 35 cycles. For Southern blot analysis of rescued colonies, 15 mg of genomic DNA was digested overnight and the restriction fragments were separated on a 0.8% agarose gel. The following 32 P-labeled probes were generated by PCR labeling: c-myc, using pRC/CMV-cmyc (Berns et al., 1997) ; N-myc, using a plasmid harboring a full-length mouse N-myc cDNA
Rescue of c-myc null phenotype K Berns et al type of screen, we ®rst focused on the identi®cation of c-myc-positive colonies. We performed PCR reactions using retroviral vector-speci®c primers (gag and SupF). The ampli®ed cDNA inserts were separated on an agarose gel and analysed by Southern blotting with a cmyc speci®c probe. This assay indicated that all the fast-growing variants derived from the K562 cDNA library infection contained a (near) full-length (2.0 ± 2.2 kb) c-myc cDNA.
Next, the rescue screen was performed twice with a size fractionated human JEG3 choriocarcinoma-derived cDNA library. In these experiments, fast-growing variants were found both in pools of cells infected with the 1 ± 3 kb and 43 kb cDNA size fractions of the library (Table 1) . Subsequent PCR ampli®cation of the retroviral cDNA inserts followed by hybridization of the PCR products with both c-myc and N-myc speci®c probes suggested that a subset of the fast-growing colonies did not contain a c-myc or N-myc cDNA insert. The morphology of the fast-growing non-myc containing clones was nevertheless very similar to those that did contain myc. We therefore performed a Southern blot analysis on genomic DNA isolated from these colonies. Genomic DNA was digested with XbaI (which releases the cDNA insert and the retroviral vector-derived SupF sequence) and probed with an Nmyc speci®c probe. This experiment revealed that all the non-c-myc rescued colonies contained N-myc cDNA library inserts of 3.0 ± 3.3 kb (data not shown). Apparently, under the conditions used, the PCR reaction did not amplify the N-myc cDNA inserts from the retroviral vectors, yielding a false-negative result.
Finally, we infected the c-myc null cells with a whole mouse embryo-derived cDNA library and subdivided the infected cells in 30 pools. After 4 ± 5 weeks, rescued colonies were identi®ed in seven pools. Again, multiple clones were isolated and genomic DNA from rescued clones was subjected to Southern analysis. Also in this screen, only c-myc cDNA inserts were cloned (Table 1) .
In summary, despite extensive eorts we have been unable to identify genes, other than Myc family members, that rescue the slow growth phenotype of c-myc null ®broblasts. It is unlikely that this is due to inadequate screening eciency, complexity, or size representation of the retroviral cDNA libraries, as full length c-myc (2.2 kb) and N-myc (3.5 kb) cDNAs were each independently isolated several times. However, it remains possible that such genes indeed exist, but were not present in the cDNA libraries used. The observation that potent cell cycle regulators, such as SV40 Tantigen and adenovirus E1A, did not rescue the slow growth phenotype of the c-myc null cells suggests that the cell cycle components that are deregulated by these viral proteins are not among the critical targets of cMyc. Recently, the cyclin-dependent kinase CDK4 was identi®ed as a critical target of c-Myc since it could partially alleviate the c-myc null growth defect (Hermeking et al., 2000) . However, in our hands a cmyc null derivative that over-expressed the tumorderived CDK4/R24C mutant (Wolfel et al., 1995) did not even show a partial rescue of the growth defect (data not shown). This apparent discrepancy may be caused by the fact that the CDK4/R24C mutant has a reduced ability to bind the CDK4/6 inhibitor p16 INK4A and therefore more experiments are required to clarify this issue.
Our results are compatible with a model in which cMyc is a pleiotropic factor that controls many aspects of cell growth through a number of distinct target genes, some of which may be activated by c-Myc, others repressed. The fact that spontaneous fastgrowing revertants of the c-myc null phenotype were never recovered also favors this multiple target model. Since E1A is likely to regulate at least some of the cMyc target genes required for cell proliferation, a A B Figure 2 Schematic representation of a retroviral cDNA library rescue screen. (a) c-myc null cells were infected three consecutive rounds with high titer library virus resulting in 25 to 80% infected cells. Two days after infection, cells were divided into 10 ± 30 pools and plated at low density. When plates became con¯uent, cells were split initially 1 : 3, later 1 : 4, 1 : 10 and ®nally at a dilution of 1 : 50. The last plating at very low density allowed the identi®cation of fast-growing single colonies in a background of slow-growing colonies, an example of which is shown in b. Rescued colonies are readily detectable within the non-rescued population (I) since multiple colonies arise from a single rescue event in the culture protocol used and they are denser and bigger retroviral cDNA library screen in E1A overexpressing myc null cells may allow us to identify genes that collaborate with E1A in rescue of the c-myc null growth defect.
In conclusion, our data suggest that the human and murine genomes do not harbor functional equivalents of Myc family proteins and also suggest that there are no Myc-activated genes that can substitute for c-Myc in stimulation of cell proliferation.
